THE TAPE
PLXS · Circuit Boards · $5.5B

Plexus Corp

$206.10▼ −1.13%
Last close
Relative strength
43RS
of 99, against every stock▼ -26 on the month
Falling back
Caution
−20.5%
six months against the S&P 500
52-week range
−32.9%
from the high
$132.03$307.06
Setup
blue skyplayed out
−25.3%
against the pivot at $275.83
No report date on the calendar.
Growth REALProof PENDING
Quarter to Jul 4, revenue +28% on a year ago
11/16 O 202.30 H 207.42 L 201.15 Vol 212.3K
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS43
vs pivot−25.28%
Tightening0.99×
Dry-up1.21×
Up/down vol0.03
From high33%
played out2 of 9checks
Previous breakout stopped out ▼ −9.88% in Mar
Falling back
Support and resistance
Support below
None within the last 120 sessions
Resistance above
$217.61
+5.6% · tested 3× · last 3 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 3.6 weeks and fell 11% from its ceiling at its deepest. The pivot is $275.83, and the stock closed 25.3% below it. Its relative strength rating is 43.

Against its industry
CautionBehind its industry over all three, in an industry that is not ahead of the S&P 500.
One month against the S&P 500
-7.8%
Three months against the S&P 500
-15.6%
Six months against the S&P 500
-20.5%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 6.0% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$4.0B
+28.1% year on year
Operating margin
5.7%
gross 11.4%
Net margin
4.6%
Free cash flow
$61.9M
1.1% of market cap
Price to sales
1.36×
Price to earnings
29.6×

Twelve months to Jul 4, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 28

The prior quarter: the 10-Q for this report is not filed yet.

Key takeaway
Real growth, but execution and cash generation are not yet proven.
Revenue
$1.3M
+12.1% QoQ · +28.1% YoY
Gross margin
10069.1%
-171.5 pts QoQ
Net income
$43.0M
Positive
Free cash flow
−$754.0K
Burning

What the numbers say

  • Good: Revenue +28.1% year over year, +12.1% on the quarter
  • Weak: Gross margin 10069.1%, -171.5 points on the quarter
  • Good: Profitable: net income $43M, operating margin 4695.1%
  • Weak: Burning cash: operating cash flow $26M, free cash flow -$754K, worse than $16M last quarter
  • Weak: Growth externally funded: capex $27M against operating cash flow $26M
  • Good: Net cash $314M · cash $314M
Revenue by quarter
Free cash flow
Net income
shares -0.9% in a year · net cash $314.1M

What is not obvious

  • Weak: Cash flow quality: operating cash flow $26M included a $37M deferred-revenue inflow; -$11M without it. Customers paid ahead of delivery
  • Weak: Stock compensation $21M added back, 82% of operating cash flow; $5M after it
  • Margin quality: depreciation and amortisation $19M is 1446% of revenue; gross margin 10069.1% reads 8623.3% if it is charged there
  • Weak: Capital intensity: $27M of capex on $1M of revenue this quarter, $109M over four quarters (0.0× revenue). Expansion is not self-funded

The desk’s own read

Flagged as drifting down since the report

Final read
Growth: REAL · Economic proof: PENDING
Key question: Can the growth turn into durable profit and cash after its costs and financing?
The next test is gross margin: gross margin 10069.1%, -171.5 points on the quarter.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 2 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 bought new.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
GappedTape · 2026-11-10
+7.0%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-11-06
-9.2%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-10-30
-9.6%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ down on earningsTape · 2026-10-30
-9.6% on earnings 2026-10-28
No measurable effect: stocks behave like random ones over the next three sessions (665 cases over 44 nights).
Unusual volumeTape · 2026-10-30
3.6 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Reported resultsFiling · 2026-10-29
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Unusual volumeTape · 2026-10-29
5.2 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Earnings comingEvent · 2026-10-27
reports 2026-10-28 amc
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
18
$3,991,608 total

Sold: Kelsey Todd P., Rapp Karen Marie, SCHROCK MICHAEL V, Running Michael J..

Not counted above: 2 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-10-21 Kelsey Todd P. · President & CEO, Directorsell779$185,767
2026-10-21 Kelsey Todd P. · President & CEO, Directorsell721$172,980
2026-09-16 Kelsey Todd P. · President & CEO, Directorsell1,500$363,615
2026-09-15 Abuhl David Westen · Sr. VP & CFOoption exercise2,500
2026-09-15 Abuhl David Westen · Sr. VP & CFOwithheld for tax800$190,824
2026-08-31 Rapp Karen Marie · Directorsell500$120,435
2026-08-19 Kelsey Todd P. · President & CEO, Directorsell319$79,364
2026-08-19 Kelsey Todd P. · President & CEO, Directorsell681$170,989

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

2 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy2
Buy3
Hold0
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray
4w · 11%

The most recent of 3 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Plexus Corp (PLXS) — The Tape